1. Home
  2. FPI vs MLYS Comparison

FPI vs MLYS Comparison

Compare FPI & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPI
  • MLYS
  • Stock Information
  • Founded
  • FPI 2013
  • MLYS 2019
  • Country
  • FPI United States
  • MLYS United States
  • Employees
  • FPI N/A
  • MLYS N/A
  • Industry
  • FPI Real Estate Investment Trusts
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPI Real Estate
  • MLYS Health Care
  • Exchange
  • FPI Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • FPI 607.9M
  • MLYS 634.6M
  • IPO Year
  • FPI 2014
  • MLYS 2023
  • Fundamental
  • Price
  • FPI $11.50
  • MLYS $9.78
  • Analyst Decision
  • FPI
  • MLYS Strong Buy
  • Analyst Count
  • FPI 0
  • MLYS 2
  • Target Price
  • FPI N/A
  • MLYS $30.00
  • AVG Volume (30 Days)
  • FPI 417.5K
  • MLYS 238.6K
  • Earning Date
  • FPI 02-26-2025
  • MLYS 11-11-2024
  • Dividend Yield
  • FPI 2.04%
  • MLYS N/A
  • EPS Growth
  • FPI N/A
  • MLYS N/A
  • EPS
  • FPI 0.32
  • MLYS N/A
  • Revenue
  • FPI $58,465,000.00
  • MLYS N/A
  • Revenue This Year
  • FPI N/A
  • MLYS N/A
  • Revenue Next Year
  • FPI N/A
  • MLYS N/A
  • P/E Ratio
  • FPI $36.62
  • MLYS N/A
  • Revenue Growth
  • FPI 1.30
  • MLYS N/A
  • 52 Week Low
  • FPI $9.70
  • MLYS $7.95
  • 52 Week High
  • FPI $12.85
  • MLYS $16.91
  • Technical
  • Relative Strength Index (RSI)
  • FPI 48.91
  • MLYS 35.13
  • Support Level
  • FPI $11.23
  • MLYS $8.60
  • Resistance Level
  • FPI $11.99
  • MLYS $13.37
  • Average True Range (ATR)
  • FPI 0.23
  • MLYS 0.92
  • MACD
  • FPI -0.01
  • MLYS -0.34
  • Stochastic Oscillator
  • FPI 72.89
  • MLYS 25.47

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

Share on Social Networks: